Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci

The CRISPR-Cas9 nuclease system holds enormous potential for therapeutic genome editing of a wide spectrum of diseases. Large efforts have been made to further understanding of on- and off-target activity to assist the design of CRISPR-based therapies with optimized efficacy and safety. However, cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessard, Samuel, Francioli, Laurent, Alfoldi, Jessica, Tardif, Jean-Claude, Ellinor, Patrick T., MacArthur, Daniel G., Lettre, Guillaume, Orkin, Stuart H., Canver, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2017
Materias:
PNAS Plus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748207/
https://www.ncbi.nlm.nih.gov/pubmed/29229813
http://dx.doi.org/10.1073/pnas.1714640114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748207/
https://www.ncbi.nlm.nih.gov/pubmed/29229813
http://dx.doi.org/10.1073/pnas.1714640114

Ejemplares similares